Chitosan/siRNA nanoparticle-mediated TNF-alpha knockdown in peritoneal macrophages for anti-inflammatory treatment in a murine arthritis model.

[1]  H. Soifer,et al.  Chemical modification patterns compatible with high potency dicer-substrate small interfering RNAs. , 2008, Oligonucleotides.

[2]  S. Im,et al.  Chitosan oligosaccharide (COS) inhibits LPS-induced inflammatory effects in RAW 264.7 macrophage cells. , 2007, Biochemical and biophysical research communications.

[3]  L. Ivashkiv,et al.  Suppression of the Effector Phase of Inflammatory Arthritis by Double-Stranded RNA Is Mediated by Type I IFNs1 , 2007, The Journal of Immunology.

[4]  Y. Kirino,et al.  Tumor necrosis factor alpha acceleration of inflammatory responses by down-regulating heme oxygenase 1 in human peripheral monocytes. , 2007, Arthritis and rheumatism.

[5]  N. Van Rooijen,et al.  Tumor Necrosis Factor (TNF) Protects Resistant C57BL/6 Mice against Herpes Simplex Virus-Induced Encephalitis Independently of Signaling via TNF Receptor 1 or 2 , 2006, Journal of Virology.

[6]  Kenneth A Howard,et al.  RNA interference in vitro and in vivo using a novel chitosan/siRNA nanoparticle system. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[7]  Takeshi Kobayashi,et al.  A carbohydrate recognition-based drug delivery and controlled release system using intraperitoneal macrophages as a cellular vehicle. , 2006, Cancer research.

[8]  John J Rossi,et al.  Rational design and in vitro and in vivo delivery of Dicer substrate siRNA , 2006, Nature Protocols.

[9]  D. Scherman,et al.  Efficient new cationic liposome formulation for systemic delivery of small interfering RNA silencing tumor necrosis factor alpha in experimental arthritis. , 2006, Arthritis and rheumatism.

[10]  Paul A. Serbinowski,et al.  A structural basis for discriminating between self and nonself double-stranded RNAs in mammalian cells , 2006, Nature Biotechnology.

[11]  A. Lee,et al.  Design of noninflammatory synthetic siRNA mediating potent gene silencing in vivo. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  Mark E. Davis,et al.  Functional polarity is introduced by Dicer processing of short substrate RNAs , 2005, Nucleic acids research.

[13]  R. Schiffelers,et al.  Effects of treatment with small interfering RNA on joint inflammation in mice with collagen-induced arthritis. , 2005, Arthritis and rheumatism.

[14]  Sangdun Choi,et al.  Synthetic dsRNA Dicer substrates enhance RNAi potency and efficacy , 2005, Nature Biotechnology.

[15]  M. Murakami,et al.  Mechanism of macrophage activation by chitin derivatives. , 2005, The Journal of veterinary medical science.

[16]  R. Bräuer,et al.  Anti-CD4 monoclonal antibody treatment in acute and early chronic antigen induced arthritis: influence on macrophage activation , 2004, Annals of the rheumatic diseases.

[17]  Luhang Zhao,et al.  Receptor-mediated stimulatory effect of oligochitosan in macrophages. , 2004, Biochemical and biophysical research communications.

[18]  D. Sørensen,et al.  Cationic liposome-mediated delivery of siRNAs in adult mice. , 2003, Biochemical and biophysical research communications.

[19]  Judy Lieberman,et al.  Interfering with disease: opportunities and roadblocks to harnessing RNA interference , 2003, Trends in Molecular Medicine.

[20]  Mouldy Sioud,et al.  Gene silencing by systemic delivery of synthetic siRNAs in adult mice. , 2003, Journal of molecular biology.

[21]  A. Moore.  Collagen-induced arthritis. , 2003, Methods in molecular biology.

[22]  G. Laurent,et al.  Adhesion Molecule–dependent Mechanisms Regulate the Rate of Macrophage Clearance During the Resolution of Peritoneal Inflammation , 2002, The Journal of experimental medicine.

[23]  P. Taylor,et al.  Immunotherapy for rheumatoid arthritis. , 2001, Current opinion in immunology.

[24]  R. Kinne,et al.  Systemic macrophage activation in locally-induced experimental arthritis. , 2001, Journal of autoimmunity.

[25]  T. Tuschl,et al.  Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells , 2001, Nature.

[26]  W. Arend,et al.  Physiology of cytokine pathways in rheumatoid arthritis. , 2001, Arthritis and rheumatism.

[27]  M. Feldmann,et al.  Evaluation of TNF-α and IL-1 Blockade in Collagen-Induced Arthritis and Comparison with Combined Anti-TNF-α/Anti-CD4 Therapy1 , 2000, The Journal of Immunology.

[28]  K. Ulbrich,et al.  Influence of hydrophilicity of cationic polymers on the biophysical properties of polyelectrolyte complexes formed by self-assembly with DNA. , 2000, Biochimica et biophysica acta.

[29]  G. Burmester,et al.  Macrophages in rheumatoid arthritis , 2000, Arthritis research.

[30]  K. Ulbrich,et al.  Decreased Binding to Proteins and Cells of Polymeric Gene Delivery Vectors Surface Modified with a Multivalent Hydrophilic Polymer and Retargeting through Attachment of Transferrin* , 2000, The Journal of Biological Chemistry.

[31]  P. Richards,et al.  Liposomal clodronate eliminates synovial macrophages, reduces inflammation and ameliorates joint destruction in antigen-induced arthritis. , 1999, Rheumatology.

[32]  J. Woody,et al.  Repeated therapy with monoclonal antibody to tumour necrosis factor α (cA2) in patients with rheumatoid arthritis , 1994, The Lancet.

[33]  M. Feldmann,et al.  Synergy between anti-CD4 and anti-tumor necrosis factor in the amelioration of established collagen-induced arthritis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[34]  M. Feldmann,et al.  Anti-tumor necrosis factor ameliorates joint disease in murine collagen-induced arthritis. , 1992, Proceedings of the National Academy of Sciences of the United States of America.